key: cord-0809765-u2xdfm3d authors: Betonico, Gustavo Navarro; Azevedo, Luciano Cesar Pontes title: Approaching COVID‐19 ‐ bedside strategies for intensive care date: 2020-06-20 journal: Eur J Clin Invest DOI: 10.1111/eci.13327 sha: 3f3ade4f57e1251b13cb4f80c9761b7ef66e023d doc_id: 809765 cord_uid: u2xdfm3d The spread of novel coronavirus disease (COVID‐19) urged a never‐seen coordinated global response to prepare the health system, including primary care, hospital facilities and intensive care units (ICUs). Lessons have been learned from countries who suffered the pandemic at the beginning, helping the ones which are on different phases of the spreading curve. Currently, optimizing intensive care resources is mandatory as admittance to the ICUs remains rising exponentially. While public and private health system struggle for changing the slope of the curve, intensivists prepare the facilities for a tsunami of respiratory failure patients with COVID‐19.(1) This article is protected by copyright. All rights reserved the clinical picture of these patients is very similar to the previous reported literature, with mean age at fifty's, 58% male, a high prevalence of hypertension (58%) and significant disease severity (64% on invasive mechanical ventilation and 51% on vasoactive drugs). Unfortunately, few data are available regarding overall Brazilian ICU scenario, because the country has distinct public and private healthcare systems and information is not available for ICU patients from both of them. Brazilian private system is responsible for the care of 25% of Brazilian population that has access to private insurance. For these patients, the rate of 25/100,000 ICU beds per inhabitants is a better number than several high-income countries. These units were the first to receive COVID-19 cases in Brazil, following the wealthiest people that had travelled to Europe and other countries. On the other hand, for the remaining 75% of the population, the number of ICU beds in the public system is 7.6/100,000 inhabitants, a rate that per se is not inadequate. However, the distribution of these beds is very unequal, with large poorest regions of the country lacking ICU beds. These beds are progressively being filled by COVID-19 cases, and provisory hospitals and ICU beds are being built in order receive these patients. In this difficult epidemiological scenario, there is a clear expectation of witnessing a measles, dengue, and COVID-19 syndemic, among other conditions that afflict the Brazilian people. In this context, the healthcare system, especially in the northeast ant northern Brazil, is not prepared to face this pandemic that is growing at alarming rates across the world. 3 As an example, when the pandemic hit Maranhão, a northern very low income state located in Amazonia, with 6.8 million population, it had only 232 intensive care beds, concentrated in just three cities. After hustling to build out capacity, it has 761 ICU beds and offers some level of intensive care in 11 cities, according to state authorities. Two field hospitals are being built in order to bring the number of ICU beds to 910. However, untrained staff and lack of expertise on critical care will challenge the public and private health system located on Brazilian Northeast and North regions. This article is protected by copyright. All rights reserved When the usual intensive-care interventions are withheld, comprehensive and adequate palliative care must be provided. 5 Regarding the intensive care in COVID-19 patients, primary target organs are usually the lungs. Previous studies report an incidence of 10 to 15% of COVID-19 patients requiring ventilatory support due to respiratory failure. At the first beginning of the pandemic, the protocols guided that patients developing O 2 need through nasal catheter greater than 5 liters/minute to maintain SpO2 > 93% and/or have respiratory rate > 28 respiratory incursions per minute or CO 2 retention (PaCO 2 >50 mmHg and/or pH < 7.25) should be promptly intubated and ventilated mechanically. However, this strategy has been questioned and postponing intubation trough highflow nasal catheters and helmet-mask noninvasive ventilation could be a strategy in a well-trained ICU team. 6, 7 Strategies such as prone positioning in awake patients associated with high flow nasal catheters have been used and are associated with improvements in hypoxemia in these patients. 6 Whenever invasive mechanical ventilation needs to be stablished, rapid-sequence intubation must be performed and safety procedures for airborne transmission followed, like complete PPE, occlusion of the endotracheal tube and the use of capnography devices to check for the correct tube position. Before starting ventilation on COVID-19 patients with severe lung disease, one must try to identify two different phenotypes. The one "type L", is characterized by high pulmonary compliance associated with low response to positive end expiratory pressure PEEP. The other This article is protected by copyright. All rights reserved phenotype, "type H", seems to be more like typical acute respiratory distress (ARDS) and is associated with high elastance and better response to higher PEEP. 8 The progressive increase of inflammation and an unusual trend of hypercoagulation could be responsible for prolonged mechanical ventilation in COVID patients, but there is still controversial data on this issue. 10 Weaning process follows the same steps and criteria of patients with ARDS or severe respiratory failure. It is necessary to ensure a clinical improvement that allows adequate levels of sedoanalgesia in order to perform a Spontaneous Breathing Trial (EBT). The use of T-piece is not recommended due to the aerosolization risk. Following success in EBT, patient should be extubated (or disconnected from the ventilator if tracheostomized) and placed on O2 supplementation. Similarly as in pre-intubation step it is recommended a nasal catheter with maximum O2 of 5l/min to avoid airborne particles. Regarding tracheostomized patients, This article is protected by copyright. All rights reserved appropriate Heat and Moisture Exchange (HME) filter with lateral input should be placed for supplementary oxygen flow, avoiding the tracheostomy mask. In very specific cases one can choose noninvasive ventilation or high-flow nasal catheter after extubating, but aerosolization risk must be weighted. 7 The hemodynamic profile is also affected by COVID-19 disease. Specifically for the mechanically ventilated patients, vasoactive drugs such as norepinephrine is often necessary. Whether this reflects sepsis-induced hypotension or is secondary to the high requirement of sedative to maintain adequate ventilation is unknown. On the other hand, the fluid management of these patients is usually very conservative, similar to protocols used in ARDS in general and in COVID-19-associated ARDS in particular. 11 A subgroup of COVID-19 patients with critical illness has a significant release of inflammatory mediators, mimicking a cytokine storm. 12 Evidences suggesting this picture includes increased concentrations of interleukin (IL)-2, IL-7, granulocyte colony stimulating factor, interferon-γ inducible protein 10, monocyte chemoattractant protein 1, macrophage inflammatory protein 1-α, and tumor necrosis factor-α. 13 Also, these patients commonly have increased ferritin and IL-6 concentrations, and elevations of both markers are independent factors associated with poor outcomes in this scenario. 14 Possible interventions to ameliorate cytokine storm in this subgroup are corticosteroids, IL-1 blockade with anakinra and IL-6 blockade with tocilizumabe, but all these interventions lack adequate evidences produced by randomized clinical trials. Another concern addresses the clinical findings of thrombotic events and coagulation activation during COVID-19. At the very beginning of the pandemic, studies demonstrated an association between increased D-dimer concentrations and worse prognosis in these patients. 15 Later studies suggested significant activation of the coagulation pathways highlighting a subgroup of COVID-19 patients with high risk of arterial and venous thrombotic events. 16, 17 The use of prophylactic heparin was associated with better prognosis in small retrospective studies. 18 Taken together, these results suggest that coagulation disturbances are part of the pathogenesis of COVID-19-induced multiple organ failure. Whether this is an epiphenomenon or is an important pathway amenable to therapeutic intervention with anticoagulants remains to be fully discovered. During COVID-19 pandemic, best practices compliance sometimes are not undertaken in an attempt to find the optimal solution for each patient. On the other hand, lessons learned from bedside experience managing COVID-19 patients can help to anticipate critical issues and prepare the ICU team to maximize safety and incorporate clinical expertise. Intensive care practitioners This article is protected by copyright. All rights reserved should review critical care treatment regularly and when the patient's clinical condition changes. This review includes an assessment of whether the treatment goals are clinically realistic or not. One should interrupt critical care treatment when it is no longer considered possible to achieve the desired outcomes, but the decision will never rely on economic, social or religious issues, but on frailty scores, for example Clinical Frailty Score (CFS) or another medical reason. Recording the palliative care decision shared with the family is essential to leave any doubt and to reduce conflicts. Because cardiopulmonary resuscitation brings great hazard to health care involved, this situation must be weighted in patients with CFS more than 5. 19 Sharing experiences and devoting time searching for answers to the above issues should be a coordinate and scientific-based effort. In addition, each health facility should stimulate the development of local protocols adapted to its resources, staff training and cultural peculiarities, keeping in mind that COVID-19 pandemic will soon refrain but a second peak will occur, as the slope of the curve become flattened and the end of lockdown become closer Conflict of interest: Betônico, GN and Azevedo, LCP declare that they have no financial or ethical conflict of interest. Preparing for COVID-19: early experience from an intensive care unit in Singapore COVID-19 in Piauí: initial scenario and perspectives for coping COVID-19 pandemic: triage for intensive-care treatment under resource scarcity Protecting healthcare workers from SARS-CoV-2 infection: practical indications Orientações Sobre o Manuseio Do Paciente Com Pneumonia e Insuficiência Respiratória Devido a Infecção Pelo Coronavírus COVID-19 pneumonia : different respiratory treatment for different phenotypes ? Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome COVID-19 : towards understanding of pathogenesis Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) COVID-19: consider cytokine storm syndromes and immunosuppression Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Accepted Article This article is protected by copyright Incidence of thrombotic complications in critically ill ICU patients with COVID-19 Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy COVID-19 rapid guideline: critical care in adults Accepted Article